Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine

Neurology

Volumn 62, Issue 9, 2004, Pages 1623-1625

  Strupp, M ^a,b   Kalla, R ^a   Dichgans, M ^a   Freilinger, T ^a   Glasauer, S ^a   Brandt, T ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; ACETAZOLAMIDE; POTASSIUM CHANNEL BLOCKING AGENT;

ADULT; ARTICLE; ATAXIA; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CELL FUNCTION; CLINICAL FEATURE; DISEASE COURSE; EPISODIC ATAXIA TYPE 2; FEMALE; GENE MUTATION; HUMAN; MALE; PRIORITY JOURNAL; PURKINJE CELL; RECURRENT DISEASE;

EID: 2342663131     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000125691.74109.53     Document Type: Article

References (10)

1. Griggs RC, Nutt JG. Episodic ataxias as channelopathies. Ann Neurol 1995;37:285-287.
2. Jen J, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology 2004;62:17-22.
3. Griggs RC, Moxley RT III, Lafrance RA, McQuillen J. Hereditary paroxysmal ataxia: response to acetacolamide. Neurology 1978;28:1259-1264.
4. 2+ channel gene CACNL1A4. Cell 1996;87:543-552.
5. Hille B. Ionic channels of excitable membranes. 3rd ed. Sunderland, MA: Sinauer Associates, 2001.
6. Kullmann DM. The neuronal channelopathies. Brain 2002;125:1177-1195.
7. Strupp M, Schüler O, Krafczyk S, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine-a placebo-controlled study. Neurology 2003;61:165-170.
8. Etzion Y, Grossman Y. Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells. Exp Brain Res 2001;139:419-425.
9. Hirose H, Arayama T, Takita J, Igarashi T, Hayashi Y, Nagao Y. A family of episodic ataxia type 2: no evidence of genetic linkage to the CACNA1A gene. Int J Mol Med 2003;11:187-189.
10. Jouvenceau A, Eunson LH, Spauschus A, et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 2001;358:801-807.